White S L, Zhou M Y, Low R B, Periasamy M
Department of Molecular Physiology and Biophysics, University of Vermont College of Medicine, Burlington, Vermont 05405, USA.
Am J Physiol. 1998 Aug;275(2):C581-9. doi: 10.1152/ajpcell.1998.275.2.C581.
Smooth muscle myosin heavy chains (MHCs), the motor proteins that power smooth muscle contraction, are produced by alternative splicing from a single gene. The smooth muscle MHC gene is capable of producing four isoforms by utilizing alternative splice sites located at the regions encoding the carboxy terminus and the junction of the 25- and 50-kDa tryptic peptides. These four isoforms, SM1A, SM1B, SM2A, and SM2B, are a combination of one of two heavy chains containing different carboxy-terminal tails (1 or 2) without (A) or with (B) an additional motif in the myosin head. In the present study, using RNA analysis and isoform-specific antibodies, we demonstrate the expression patterns of MHC isoforms during development in rat smooth muscle tissues. RNase protection analysis indicates that the mRNAs for SMA and SMB isoforms, which differ by a 21-nucleotide insertion in the region encoding the S1 head region of the myosin molecule, are differentially expressed during development in a highly tissue-specific manner. Smooth muscle MHC transcripts are first detectable in developing rat smooth muscle tissues at 17 days of fetal development. The SMB mRNA is shown to be expressed in smooth muscle from fetal bladder, intestine, and stomach and from neonatal aorta; however, it is not expressed in cultured smooth muscle cells from rat aorta. The SMA mRNA is also present at all stages of development in the smooth muscles examined; however, it is much less abundant than SMB mRNA in most fetal smooth muscles. We show here that the SMB isoform, which contains a unique seven-amino acid insertion at the junction of the 25- and 50-kDa tryptic peptides, is present in conjunction with SM1 and SM2 tails on immunoblots of smooth muscle from stomach, intestine, bladder, and uterus and is expressed during development in a pattern distinct from that of the SM1 and SM2 tail isoforms.
平滑肌肌球蛋白重链(MHCs)是驱动平滑肌收缩的运动蛋白,由单个基因通过可变剪接产生。平滑肌MHC基因能够通过利用位于编码羧基末端以及25 kDa和50 kDa胰蛋白酶肽连接处的可变剪接位点产生四种异构体。这四种异构体,即SM1A、SM1B、SM2A和SM2B,是由两条重链中的一条与不同的羧基末端尾巴(1或2)组合而成,在肌球蛋白头部没有(A)或有(B)一个额外的基序。在本研究中,我们使用RNA分析和异构体特异性抗体,展示了大鼠平滑肌组织发育过程中MHC异构体的表达模式。核糖核酸酶保护分析表明,SMA和SMB异构体的mRNA在编码肌球蛋白分子S1头部区域的区域相差21个核苷酸插入,在发育过程中以高度组织特异性的方式差异表达。平滑肌MHC转录本在胎儿发育17天时首次在发育中的大鼠平滑肌组织中被检测到。SMB mRNA在胎儿膀胱、肠道和胃以及新生主动脉的平滑肌中表达;然而,它在大鼠主动脉的培养平滑肌细胞中不表达。SMA mRNA在所检查的平滑肌发育的所有阶段也都存在;然而,在大多数胎儿平滑肌中,它的丰度远低于SMB mRNA。我们在此表明,在25 kDa和50 kDa胰蛋白酶肽连接处含有独特的七个氨基酸插入的SMB异构体,在胃、肠道、膀胱和子宫平滑肌的免疫印迹中与SM1和SM2尾巴同时存在,并且在发育过程中的表达模式与SM1和SM2尾巴异构体不同。